Researchers Isolated Skin-Derived Bacteriophages
Scientists identified two viruses capable of targeting bacteria and disrupting biofilms on human skin.
Updated on Oct. 8, 2026 in Life Sciences
Live Poll
Should medical research prioritize bacteriophage therapy as a viable alternative to traditional antibiotic treatments?
Researchers have successfully isolated four bacteriophages from human facial skin swabs. Two of these phages demonstrated significant potential in laboratory testing as treatments for biofilm-related bacterial infections.
Why it matters
Bacteriophage therapy serves as a critical alternative to traditional antibiotics, especially for infections involving persistent biofilm development. By utilizing viruses that naturally occur on skin, researchers aim to develop safer treatments without the risk of antibiotic resistance.
The study utilized Galleria mellonella infection models to confirm the therapeutic potential of phages Se_20 and Se_42. These phages reduced preformed biofilm biomass by up to 86.3% and planktonic bacterial counts by more than 3 log10 CFU/mL.
The players
Galleria mellonella
This insect species is frequently used as an in vivo model for testing the efficacy of novel antimicrobial therapies.
The details
The isolated phages, identified as Se_20 and Se_42, lack virulence factors and antimicrobial resistance genes, which supports their potential for clinical use. Laboratory analysis confirmed both phages possess a 25-minute latent period, with Se_20 exhibiting a burst size of 142 PFU per cell compared to 70 PFU per cell for Se_42.
Timeline
Planktonic bacterial counts were reduced by the phages within 4 to 6 hours.
The latent period for both identified bacteriophages is 25 minutes.
The Big Picture
This research provides a new candidate for phage-based therapeutic interventions in dermatology. It shifts the current paradigm by focusing on phages naturally sourced from human skin, potentially facilitating better compatibility for future clinical applications.
Future development of these bacteriophages could lead to targeted topical treatments that clear harmful skin bacteria without the common side effects of antibiotics. This could eventually provide patients with more effective options for managing skin-related bacterial conditions.
The takeaway
The successful isolation of these phages demonstrates the potential for leveraging the skin microbiome to fight infection. Researchers are now moving toward preclinical evaluations to determine if these results can be translated into human therapeutic products.
Further reading
Learn more about the latest innovations in Life Sciences.
More information
Read the complete peer-reviewed research article on the study findings.
Source note: This article includes information reported by Nature.
Live Poll
Should medical research prioritize bacteriophage therapy as a viable alternative to traditional antibiotic treatments?
